# WAVECREST Post Market Clinical Follow-Up (PMCF) Study

> **NCT03204695** · NA · TERMINATED · sponsor: **Coherex Medical** · enrollment: 27 (actual)

## Conditions studied

- Non-valvular Atrial Fibrillation

## Interventions

- **DEVICE:** Percutaneous LAA Closure
- **DRUG:** Anticoagulation or Clopidogrel

## Key facts

- **NCT ID:** NCT03204695
- **Lead sponsor:** Coherex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-29
- **Primary completion:** 2018-06-14
- **Final completion:** 2018-06-14
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Study closed due to device design modifications.
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204695, "WAVECREST Post Market Clinical Follow-Up (PMCF) Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03204695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*